Press Releases
Quaker Chemical Announces Third Quarter 2014 Results
- 8% revenue growth on increased product volume
- Operating income drives non-GAAP earnings per diluted share up 31% to $1.19
- Net operating cash flow of approximately $30 million generated in the quarter
Mr. Barry continued, "Looking forward, we are seeing an uncertain economic environment in many countries throughout the world. However, we do believe our track record of increasing our market share and leveraging our recent acquisitions will continue and help offset the market issues we may experience. In addition, our strong cash flow and balance sheet will allow us to continue to pursue strategic, value creating acquisitions like our recent acquisition of
Third Quarter of 2014 Summary
Net sales for the third quarter of 2014 of
Gross profit increased approximately
Selling, general and administrative expenses ("SG&A") increased approximately
The Company had other income of
Interest expense was slightly lower in the third quarter of 2014 compared to the third quarter of 2013. The Company incurred additional interest expense in the current quarter on higher average borrowings due to its recent acquisition activity, but this was more than offset by prior year interest expense from the accretion of an acquisition-related earnout liability that was settled in 2014.
Interest income was higher in the third quarter of 2014 compared to the third quarter of 2013, primarily due to interest received on certain tax-related credits and an increase in the level of the Company's invested cash in regions with higher returns.
The Company's effective tax rates for the third quarters of 2014 and 2013 were 26.7% and 33.8%, respectively. The Company has historically recognized a third quarter tax rate that is lower than its annual effective tax rate. However, in the prior year, the Company's effective tax rate was impacted by its
Equity in net income of associated companies ("equity income") decreased
The
Overall, the Company realized a minimal impact to its net income from its current quarter acquisitions, as their respective operational results were offset by acquisition-related costs and initial adjustments related to fair value accounting.
Changes in foreign exchange rates positively impacted the third quarter of 2014 net income by approximately
Year-to-Date 2014 Summary
Net sales for the first nine months of 2014 of
Gross profit increased approximately
SG&A increased approximately
The
Interest expense was lower in the first nine months of 2014 compared to the first nine months of 2013, primarily due to decreases in average borrowings, lower average interest rates and the prior year interest accretion on an acquisition-related earnout liability, discussed above.
Interest income was higher in the first nine months of 2014 compared to the first nine months of 2013, primarily due to interest received on several tax-related credits and an increase in the average level of the Company's cash on hand in the current year.
The Company's effective tax rates for the first nine months of 2014 and 2013 were relatively consistent at 30.5% and 30.0%, respectively. The Company still estimates that its full year 2014 effective tax rate will approximate 31%.
The decrease in the Company's equity income of
The primary component of the
Changes in foreign exchange rates negatively impacted the first nine months of 2014 net income by approximately
Balance Sheet and Cash Flow Items
Strong quarterly earnings and improved working capital management drove net operating cash flows of approximately
Non-GAAP Measures
Included in this public release are non-GAAP financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP (unaudited) financial measures:
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
GAAP earnings per diluted share attributable to Quaker |
$ 1.18 |
$ 0.95 |
$ 3.31 |
$ 3.21 | ||||
UK pension plan amendment per diluted share |
— |
— |
0.05 |
— | ||||
U.S. customer bankruptcy per diluted share |
0.02 |
— |
0.02 |
— | ||||
Mineral oil excise tax refund per diluted share |
— |
— |
— |
(0.14) | ||||
Change in acquisition-related earnout liability per diluted share |
— |
— |
— |
0.03 | ||||
Cost streamlining initiatives per diluted share |
— |
0.05 |
0.02 |
0.07 | ||||
Currency conversion impacts of the Venezuelan Bolivar Fuerte |
— |
— |
0.02 |
0.03 | ||||
Equity income in a captive insurance company per diluted |
(0.01) |
(0.09) |
(0.16) |
(0.33) | ||||
Non-GAAP earnings per diluted share |
$ 1.19 |
$ 0.91 |
$ 3.26 |
$ 2.87 | ||||
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
Net income attributable to Quaker Chemical Corporation |
$ 15,696 |
$ 12,551 |
$ 43,853 |
$ 42,253 | ||||
Depreciation and amortization |
4,196 |
3,952 |
11,908 |
11,840 | ||||
Interest expense |
641 |
717 |
1,747 |
2,223 | ||||
Taxes on income before equity in net income of associated companies |
5,724 |
5,972 |
18,808 |
16,933 | ||||
UK pension plan amendment |
— |
— |
902 |
— | ||||
U.S. customer bankruptcy |
310 |
— |
310 |
— | ||||
Mineral oil excise tax refund |
— |
— |
— |
(2,540) | ||||
Change in acquisition-related earnout liability |
— |
— |
— |
675 | ||||
Cost streamlining initiatives |
— |
875 |
348 |
1,277 | ||||
Currency conversion impacts of the Venezuelan Bolivar Fuerte |
— |
— |
321 |
357 | ||||
Equity income in a captive insurance company |
(72) |
(1,247) |
(2,142) |
(4,378) | ||||
Adjusted EBITDA |
$ 26,495 |
$ 22,820 |
$ 76,055 |
$ 68,640 | ||||
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation | ||||||||
Condensed Consolidated Statement of Income | ||||||||
(Dollars in thousands, except per share amounts) | ||||||||
(Unaudited) |
(Unaudited) | |||||||
Three Months Ended September 30, |
Nine Months Ended September 30, | |||||||
2014 |
2013 |
2014 |
2013 | |||||
Net sales |
$ 198,867 |
$ 184,059 |
$ 571,827 |
$ 545,098 | ||||
Cost of goods sold |
128,567 |
118,069 |
368,197 |
349,186 | ||||
Gross profit |
70,300 |
65,990 |
203,630 |
195,912 | ||||
% |
35.4% |
35.9% |
35.6% |
35.9% | ||||
Selling, general and administrative expenses |
49,747 |
47,183 |
142,759 |
139,901 | ||||
Operating income |
20,553 |
18,807 |
60,871 |
56,011 | ||||
% |
10.3% |
10.2% |
10.6% |
10.3% | ||||
Other income (expense), net |
914 |
(685) |
558 |
1,962 | ||||
Interest expense |
(641) |
(717) |
(1,747) |
(2,223) | ||||
Interest income |
642 |
267 |
1,990 |
665 | ||||
Income before taxes and equity in net income of associated companies |
21,468 |
17,672 |
61,672 |
56,415 | ||||
Taxes on income before equity in net income of associated companies |
5,724 |
5,972 |
18,808 |
16,933 | ||||
Income before equity in net income of associated companies |
15,744 |
11,700 |
42,864 |
39,482 | ||||
Equity in net income of associated companies |
375 |
1,605 |
2,506 |
4,689 | ||||
Net income |
16,119 |
13,305 |
45,370 |
44,171 | ||||
Less: Net income attributable to noncontrolling interest |
423 |
754 |
1,517 |
1,918 | ||||
Net income attributable to Quaker Chemical Corporation |
$ 15,696 |
$ 12,551 |
$ 43,853 |
$ 42,253 | ||||
% |
7.9% |
6.8% |
7.7% |
7.8% | ||||
Per share data: |
||||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - |
$ 1.18 |
$ 0.95 |
$ 3.31 |
$ 3.21 | ||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - |
$ 1.18 |
$ 0.95 |
$ 3.31 |
$ 3.21 |
Quaker Chemical Corporation | ||||
Condensed Consolidated Balance Sheet | ||||
(Dollars in thousands, except par value and share amounts) | ||||
(Unaudited) | ||||
September 30, |
December 31, | |||
2014 |
2013 | |||
ASSETS |
||||
Current assets |
||||
Cash and cash equivalents |
$ 64,221 |
$ 68,492 | ||
Accounts receivable, net |
188,982 |
165,629 | ||
Inventories |
80,534 |
71,557 | ||
Prepaid expenses and other current assets |
19,818 |
23,169 | ||
Total current assets |
353,555 |
328,847 | ||
Property, plant and equipment, net |
83,796 |
85,488 | ||
Goodwill |
70,053 |
58,151 | ||
Other intangible assets, net |
59,301 |
31,272 | ||
Investments in associated companies |
21,149 |
19,397 | ||
Deferred income taxes |
21,996 |
24,724 | ||
Other assets |
34,360 |
36,267 | ||
Total assets |
$ 644,210 |
$ 584,146 | ||
LIABILITIES AND EQUITY |
||||
Current liabilities |
||||
Short-term borrowings and current portion of long-term debt |
$ 571 |
$ 1,395 | ||
Accounts and other payables |
85,888 |
75,580 | ||
Accrued compensation |
16,058 |
20,801 | ||
Other current liabilities |
28,362 |
33,080 | ||
Total current liabilities |
130,879 |
130,856 | ||
Long-term debt |
62,009 |
17,321 | ||
Deferred income taxes |
5,920 |
6,729 | ||
Other non-current liabilities |
78,391 |
84,544 | ||
Total liabilities |
277,199 |
239,450 | ||
Equity |
||||
Common stock, $1 par value; authorized 30,000,000 shares; issued |
13,269 |
13,196 | ||
Capital in excess of par value |
96,717 |
99,038 | ||
Retained earnings |
290,876 |
258,285 | ||
Accumulated other comprehensive loss |
(41,413) |
(34,700) | ||
Total Quaker shareholders' equity |
359,449 |
335,819 | ||
Noncontrolling interest |
7,562 |
8,877 | ||
Total equity |
367,011 |
344,696 | ||
Total liabilities and equity |
$ 644,210 |
$ 584,146 |
Quaker Chemical Corporation | ||||
Condensed Consolidated Statement of Cash Flows | ||||
For the Nine months ended September 30, | ||||
(Dollars in thousands) | ||||
(Unaudited) | ||||
2014 |
2013 | |||
Cash flows from operating activities |
||||
Net income |
$ 45,370 |
$ 44,171 | ||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation |
9,154 |
9,219 | ||
Amortization |
2,754 |
2,621 | ||
Equity in undistributed earnings of associated companies, net of dividends |
(2,306) |
(2,525) | ||
Deferred compensation and other, net |
1,672 |
(50) | ||
Stock-based compensation |
3,959 |
3,133 | ||
(Gain) loss on disposal of property, plant and equipment |
(125) |
193 | ||
Insurance settlements realized |
(1,214) |
(731) | ||
Pension and other postretirement benefits |
178 |
(561) | ||
(Decrease) increase in cash from changes in current assets and current liabilities, net of |
||||
Accounts receivable |
(23,061) |
(13,222) | ||
Inventories |
(9,143) |
(4,569) | ||
Prepaid expenses and other current assets |
1,332 |
1,017 | ||
Accounts payable and accrued liabilities |
9,470 |
13,256 | ||
Net cash provided by operating activities |
38,040 |
51,952 | ||
Cash flows from investing activities |
||||
Investments in property, plant and equipment |
(8,376) |
(7,330) | ||
Payments related to acquisitions, net of cash acquired |
(51,947) |
(2,478) | ||
Proceeds from disposition of assets |
178 |
391 | ||
Interest earned on insurance settlements |
34 |
40 | ||
Change in restricted cash, net |
1,180 |
691 | ||
Net cash used in investing activities |
(58,931) |
(8,686) | ||
Cash flows from financing activities |
||||
Proceeds from long-term debt |
45,000 |
- | ||
Repayment of long-term debt |
(1,106) |
(12,289) | ||
Dividends paid |
(10,580) |
(9,721) | ||
Stock options exercised, other |
(194) |
(510) | ||
Excess tax benefit related to stock option exercises |
430 |
815 | ||
Purchase of a noncontrolling interest in an affiliate |
(7,422) |
- | ||
Payment of acquisition-related earnout liability |
(4,709) |
- | ||
Distributions to noncontrolling affiliate shareholders |
(1,806) |
(30) | ||
Net cash provided by (used in) financing activities |
19,613 |
(21,735) | ||
Effect of exchange rate changes on cash |
(2,993) |
(133) | ||
Net (decrease) increase in cash and cash equivalents |
(4,271) |
21,398 | ||
Cash and cash equivalents at the beginning of the period |
68,492 |
32,547 | ||
Cash and cash equivalents at the end of the period |
$ 64,221 |
$ 53,945 |
Logo - http://photos.prnewswire.com/prnh/20120910/PH70044LOGO
SOURCE
Margaret M. Loebl, Vice President, Chief Financial Officer and Treasurer, loeblm@quakerchem.com, T. 610.832.4160